IPO/FPO Analysis
IPO and FPO reviews — what the numbers say before you subscribe.
127 articles
-
Windlas Biotech IPO Review: Scale of operations raises doubts on profitability
Incorporated in February 2001, Windlas Biotech Limited (“Windlas”) is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (“CDMO”) industry in India in terms of revenue.

-
Devyani International IPO Review: Fast Growing QSR Model
Incorporated in December 1991, Devyani International Limited is the largest franchisee of Yum Brands in India and is among the largest chain operators of quick-service restaurants (“QSR”) in India on a non-exclusive…

-
Glenmark Life Sciences IPO Review: Taking advantage of API boom
Glenmark Life Sciences Limited (“GLS”) is a Rs. 2,000 Cr developer and manufacturer of select active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas.

-
Zomato IPO Review: Potential to capture the profit pool of a fragmented industry
Zomato Limited (“Zomato”) was incorporated in Jan 2010 as “DC Foodiebay Online Services Pvt. Ltd. Today it is one of the leading Food Services platforms in India in terms of the value…

-
G R Infraprojects IPO Review: Should you subscribe to the issue?
G R Infraprojects is an Integrated Road EPC company with experience in design and construction of various road/ highway projects across 15 States in India.

-
India Pesticides IPO Review: Should you subscribe?
Incorporated in December 1984, India Pesticides Limited is one of the leading agrochemicals manufacturers in India.

-
KIMS Hospitals IPO Review: Boom in healthcare to continue
KIMS (Krishna Institute of Medical Sciences Limited) was incorporated as Jagjit Singh and Sons Private Limited in July 1973.

-
PowerGrid InvIT IPO Review: A regular income option with some risk
POWERGRID Infrastructure Investment Trust (“PGInvIT”) is an InvIT set-up to own, construct, operate, maintain and invest as an infrastructure investment trust as permissible in terms of the InvIT Regulations, including in power…

-
Mirae Asset NYSE FANG+ ETF & Fund: Should you buy?
Mirae Asset Mutual Fund has launched NYSE FANG+ Index ETF to participate in top-performing new-age businesses based out in the US.

-
Macrotech Developers (Lodha Developers) IPO Review: High risk play in high Risk sector
Macrotech Developers Ltd (MDL), earlier known as Lodha Developers, is Rs. 13,000 Cr real estate developers primarily based out in Mumbai.


